Poloxamer 407

ExcipientUNII TUF2IVW3M2

1 organisation holds 2 active FDA Type IV Drug Master Files for Poloxamer 407.

Sources: FDA List of Drug Master Files (checked 13 Nov 2026); FDA Global Substance Registration System (identity). Methodology

Active Type IV DMFs (2)

HolderDMFFiled asSubmitted
ANMOL CHEMICALS PRIVATE LTD43209POLOXAMER 407 EPFeb 2026
ANMOL CHEMICALS PRIVATE LTD43218POLOXAMER 407 BPFeb 2026

“Filed as” is the subject exactly as the holder gave it to the FDA, including the grade or pharmacopoeia it names. Holder names link to a company profile where one is published. An active filing can be referenced by a drug application; it is not proof of current supply.

What these records establish

  • A Type IV DMF is a confidential file held by the FDA for an excipient, colourant or flavour. The FDA does not approve or disapprove it; it is reviewed when a drug application references it.
  • Active means the file is open and can be referenced with the holder's letter of authorisation. It says nothing about price, capacity or current availability.
  • The holder is the organisation that filed. It is usually, but not always, the manufacturer.
  • Many excipients are supplied without any DMF, so this list is not every supplier of Poloxamer 407.

How to qualify an excipient supplier

For suppliers

Do you supply Poloxamer 407?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.